1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Transcranial Magnetic Stimulators Market
4. Market Overview
    4.1. Introduction
        4.1.1. Market Definition
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Transcranial Magnetic Stimulators Market Analysis and Forecast, 2017–2031
        4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
    5.1. Regulatory Scenario
    5.2. Prevalence rate of various Neurodisorders by region/country
    5.3. Technological Advancements
6. Global Transcranial Magnetic Stimulators Market Analysis and Forecast, by Product Type
    6.1. Introduction & Definition
    6.2. Key Findings / Developments
    6.3. Market Value Forecast, by Product Type, 2017–2031
        6.3.1. Repetitive TMS
        6.3.2. Deep TMS
        6.3.3. Others
    6.4. Market Attractiveness Analysis, by Product Type
7. Global Transcranial Magnetic Stimulators Market Analysis and Forecast, by Application
    7.1. Introduction & Definition
    7.2. Key Findings / Developments
    7.3. Market Value Forecast, by Application, 2017–2031
        7.3.1. Therapeutics
        7.3.2. Diagnostics
        7.3.3. Research
    7.4. Market Attractiveness Analysis, by Application
8. Global Transcranial Magnetic Stimulators Market Analysis and Forecast, by End-user
    8.1. Introduction & Definition
    8.2. Key Findings / Developments
    8.3. Market Value Forecast, by End-user, 2017–2031
        8.3.1. Hospitals
        8.3.2. Specialty Centers
        8.3.3. Others (research centers, academics, etc.)
    8.4. Market Attractiveness Analysis, by End-user
9. Global Transcranial Magnetic Stimulators Market Analysis and Forecast, by Region
    9.1. Key Findings
    9.2. Market Value Forecast, by Region
        9.2.1. North America
        9.2.2. Europe
        9.2.3. Asia Pacific
        9.2.4. Latin America
        9.2.5. Middle East & Africa
    9.3. Market Attractiveness Analysis, by Region
10. North America Transcranial Magnetic Stimulators Market Analysis and Forecast
    10.1. Introduction
        10.1.1. Key Findings
    10.2. Market Value Forecast, by Product Type, 2017–2031
        10.2.1. Repetitive TMS
        10.2.2. Deep TMS
        10.2.3. Others
    10.3. Market Value Forecast, by Application, 2017–2031
        10.3.1. Therapeutics
        10.3.2. Diagnostics
        10.3.3. Research
    10.4. Market Value Forecast, by End-user, 2017–2031
        10.4.1. Hospitals
        10.4.2. Specialty Centers
        10.4.3. Others (research centers, academics, etc.)
    10.5. Market Value Forecast, by Country, 2017–2031
        10.5.1. U.S.
        10.5.2. Canada
    10.6. Market Attractiveness Analysis
        10.6.1. By Product Type
        10.6.2. By Application
        10.6.3. By End-user
        10.6.4. By Country
11. Europe Transcranial Magnetic Stimulators Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast, by Product Type, 2017–2031
        11.2.1. Repetitive TMS
        11.2.2. Deep TMS
        11.2.3. Others
    11.3. Market Value Forecast, by Application, 2017–2031
        11.3.1. Therapeutics
        11.3.2. Diagnostics
        11.3.3. Research
    11.4. Market Value Forecast, by End-user, 2017–2031
        11.4.1. Hospitals
        11.4.2. Specialty Centers
        11.4.3. Others (research centers, academics, etc.)
    11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        11.5.1. Germany
        11.5.2. U.K.
        11.5.3. France
        11.5.4. Italy
        11.5.5. Spain
        11.5.6. Rest of Europe
    11.6. Market Attractiveness Analysis
        11.6.1. By Product Type
        11.6.2. By Application
        11.6.3. By End-user
        11.6.4. By Country/Sub-region
12. Asia Pacific Transcranial Magnetic Stimulators Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Product Type, 2017–2031
        12.2.1. Repetitive TMS
        12.2.2. Deep TMS
        12.2.3. Others
    12.3. Market Value Forecast, by Application, 2017–2031
        12.3.1. Therapeutics
        12.3.2. Diagnostics
        12.3.3. Research
    12.4. Market Value Forecast, by End-user, 2017–2031
        12.4.1. Hospitals
        12.4.2. Specialty Centers
        12.4.3. Others (research centers, academics, etc.)
    12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        12.5.1. China
        12.5.2. Japan
        12.5.3. India
        12.5.4. Australia & New Zealand
        12.5.5. Rest of Asia Pacific
    12.6. Market Attractiveness Analysis
        12.6.1. By Product Type
        12.6.2. By Application
        12.6.3. By End-user
        12.6.4. By Country/Sub-region
13. Latin America Transcranial Magnetic Stimulators Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Product Type, 2017–2031
        13.2.1. Repetitive TMS
        13.2.2. Deep TMS
        13.2.3. Others
    13.3. Market Value Forecast, by Application, 2017–2031
        13.3.1. Therapeutics
        13.3.2. Diagnostics
        13.3.3. Research
    13.4. Market Value Forecast, by End-user, 2017–2031
        13.4.1. Hospitals
        13.4.2. Specialty Centers
        13.4.3. Others (research centers, academics, etc.)
    13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        13.5.1. Brazil
        13.5.2. Mexico
        13.5.3. Rest of Latin America
    13.6. Market Attractiveness Analysis
        13.6.1. By Product Type
        13.6.2. By Application
        13.6.3. By End-user
        13.6.4. By Country/Sub-region
14. Middle East & Africa Transcranial Magnetic Stimulators Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast, by Product Type, 2017–2031
        14.2.1. Repetitive TMS
        14.2.2. Deep TMS
        14.2.3. Others
    14.3. Market Value Forecast, by Application, 2017–2031
        14.3.1. Therapeutics
        14.3.2. Diagnostics
        14.3.3. Research
    14.4. Market Value Forecast, by End-user, 2017–2031
        14.4.1. Hospitals
        14.4.2. Specialty Centers
        14.4.3. Others (research centers, academics, etc.)
    14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        14.5.1. GCC Countries
        14.5.2. South Africa
        14.5.3. Rest of Middle East & Africa
    14.6. Market Attractiveness Analysis
        14.6.1. By Product Type
        14.6.2. By Application
        14.6.3. By End-user
        14.6.4. By Country/Sub-region
15. Competition Landscape
    15.1. Market Player – Competition Matrix (by tier and size of companies)
    15.2. Market Share Analysis, by Company (2021)
    15.3. Company Profiles
        15.3.1. Neurosoft
            15.3.1.1. Company Overview
            15.3.1.2. Financial Overview
            15.3.1.3. Product Portfolio
            15.3.1.4. Business Strategies
            15.3.1.5. Recent Developments
        15.3.2. Magstim
            15.3.2.1. Company Overview
            15.3.2.2. Financial Overview
            15.3.2.3. Product Portfolio
            15.3.2.4. Business Strategies
            15.3.2.5. Recent Developments
        15.3.3. Nexstim plc
            15.3.3.1. Company Overview
            15.3.3.2. Financial Overview
            15.3.3.3. Product Portfolio
            15.3.3.4. Business Strategies
            15.3.3.5. Recent Developments
        15.3.4. MagVenture, Inc.
            15.3.4.1. Company Overview
            15.3.4.2. Financial Overview
            15.3.4.3. Product Portfolio
            15.3.4.4. Business Strategies
            15.3.4.5. Recent Developments
        15.3.5. BrainsWay
            15.3.5.1. Company Overview
            15.3.5.2. Financial Overview
            15.3.5.3. Product Portfolio
            15.3.5.4. Business Strategies
            15.3.5.5. Recent Developments
        15.3.6. Seber Medical
            15.3.6.1. Company Overview
            15.3.6.2. Financial Overview
            15.3.6.3. Product Portfolio
            15.3.6.4. Business Strategies
            15.3.6.5. Recent Developments
        15.3.7. Soterix Medical, Inc.
            15.3.7.1. Company Overview
            15.3.7.2. Financial Overview
            15.3.7.3. Product Portfolio
            15.3.7.4. Business Strategies
            15.3.7.5. Recent Developments
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


 
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			